MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1alpha/NDUFA4L2 axis. Han P, Zhang B, Li Y, Gao R, et al. Oncogene 2024;43:2821-2834.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han P, Zhang B, Li Y, Gao R, et al. MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1alpha/NDUFA4L2 axis. Oncogene 2024;43:2821-2834.
PMID: 39154121